Nav: Home

ACR sends letter to Congress outlining health care reform priorities

January 18, 2017

ATLANTA - The American College of Rheumatology (ACR) sent a letter to Congressional leaders ahead of actions on health policy, urging lawmakers to adopt a healthcare reform plan that is consistent with the ACR's priority of affordable and accessible healthcare for Americans living with rheumatic diseases.

The ACR stressed in the letter that any proposal should maintain the current ban on insurers excluding coverage due to pre-existing conditions; provide insurance coverage for rheumatic disease specialists and services; maintain coverage of health educational activities for patients with chronic illnesses; limit patient co-payments for specialty drugs and services; and recognize that laboratory, radiological, and infusion services should be conveniently available near the source of a rheumatology patient's medical care.

"More than 52 million people in the U.S. - one in six Americans - live with rheumatic diseases, making it the nation's leading cause of disability," said Dr. Sharad Lakhanpal, MBBS, MD, President of the ACR. "Early and appropriate treatment for rheumatic diseases like arthritis and lupus, provided by trained rheumatologists, can prevent or slow disease progression, decrease the likelihood of disability, and reduce long-term healthcare costs. The ACR looks forward to working with both Congress and the incoming Administration to ensure that every American has access to affordable, high-quality healthcare, including care for arthritis and other rheumatic diseases."

The letter stressed the need to ensure clinical rheumatologists are able to run viable medical practices, noting both the growing scarcity of rheumatologists and the increasing demand for rheumatology care.

"The CDC estimates that one in four Americans will have doctor-diagnosed arthritis by the year 2040," continued Dr. Lakhanpal. "With the rates of doctor-diagnosed arthritis on the rise, a thriving rheumatology workforce and affordable access to specialists and treatments will be critical to ensure we meet the care needs of a growing patient population."

Additionally, the ACR recommended that any reform proposal:
  • Repeals the Independent Payment Advisory Board provision;

  • Minimizes administrate burdens through the use of universal prior authorization systems for multistate health plans; and

  • Maintains the FDA's authority to approve safe, effective biosimilars to encourage market-based relief from the high costs of biologic drugs.

Read the full text of the letter here.
-end-
The American College of Rheumatology (ACR) is the nation's leading advocacy organization for the rheumatology care community, representing more than 6,400 U.S. rheumatologists and rheumatology health professionals. As an ethically driven, professional membership organization committed to improving healthcare for Americans living with rheumatic diseases, the ACR advocates for high-quality, high-value policies and reforms that will ensure safe, effective, affordable and accessible rheumatology care.

American College of Rheumatology

Related Arthritis Articles:

The ACR and the Arthritis Foundation present new guidelines offering therapeutic approaches and treatment options for juvenile idiopathic arthritis
Today, the American College of Rheumatology (ACR), in partnership with the Arthritis Foundation (AF), released two guidelines on juvenile idiopathic arthritis (JIA).
Does alcohol consumption have an effect on arthritis?
Several previous studies have demonstrated that moderate alcohol consumption is linked with less severe disease and better quality of life in patients with rheumatoid arthritis, but a new Arthritis Care & Research study suggests that this might not be because drinking alcohol is beneficial.
Prospect of a new treatment for rheumatoid arthritis
An international research group led by Charité -- Universitätsmedizin Berlin has completed testing a new drug to treat rheumatoid arthritis.
Can rare lymphocytes combat rheumatoid arthritis?
Immunologists at Friedrich-Alexander-Universität Erlangen-Nürnberg have demonstrated that ILC2, a group of rare lymphoid cells, play a key role in the development of inflammatory arthritis.
Which pain medication is safest for arthritis patients?
In a recent Alimentary Pharmacology & Therapeutics study, arthritis patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) for pain plus a stomach acid-reducing medicine called esomeprazole had infrequent gastrointestinal side effects.
More Arthritis News and Arthritis Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...